Literature DB >> 214090

Inhibition cyclic nucleotide phosphodiesterase by FPL 55712, an SRS-A antagonist.

M Chasin, C Scott.   

Abstract

Mesh：

Substances：

Year:  1978        PMID： 214090     DOI： 10.1016/0006-2952(78)90070-9

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  8 in total

1.  Antigen-induced contraction of guinea-pig isolated trachea: studies with novel inhibitors and antagonists of arachidonic acid metabolites.

Authors:  T R Jones; L Charette; D Denis
Journal:  Br J Pharmacol       Date:  1988-09       Impact factor: 8.739

2.  Evaluation of LY163443, 1-[2-hydroxy-3-propyl-4-([4- (1H-tetrazol-5-ylmethyl)phenoxy]methyl) phenyl]ethanone, as a pharmacologic antagonist of leukotrienes D4 and E4.

Authors:  J H Fleisch; L E Rinkema; K D Haisch; D McCullough; F P Carr; R D Dillard
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-05       Impact factor: 3.000

3.  Lipoxygenase metabolites mediate increased airways responsiveness to histamine after acute platelet activating factor exposure in the guinea-pig.

Authors:  G P Anderson; M R Fennessy
Journal:  Agents Actions       Date:  1988-06

4.  A possible role for leukotrienes in the regulation of glomerular haemodynamics in the dog.

Authors:  J Heller; V Horácek; S Kamarádová
Journal:  Pflugers Arch       Date:  1988-07       Impact factor: 3.657

5.  Alteration of drug responsiveness in guinea-pig lung anaphylaxis using different antigen challenge concentrations.

Authors:  A J Lewis; A Blumenthal; A Dervinis
Journal:  Agents Actions       Date:  1983-06

6.  Leukotriene induction of TxB2 in cultured bovine aortic endothelial cells.

Authors:  B Dunham; D Shepro; H B Hechtman
Journal:  Inflammation       Date:  1984-09       Impact factor: 4.092

7.  Leukotriene receptors on human pulmonary vascular endothelium.

Authors:  J L Ortiz; I Gorenne; J Cortijo; A Seller; C Labat; B Sarria; T S Abram; P J Gardiner; E Morcillo; C Brink
Journal:  Br J Pharmacol       Date:  1995-08       Impact factor: 8.739

8.  Quinidine, but not eicosanoid antagonists or dexamethasone, protect the gut from platelet activating factor-induced vasoconstriction, edema and paralysis.

Authors:  Ingmar Lautenschläger; Inéz Frerichs; Heike Dombrowsky; Jürgen Sarau; Torsten Goldmann; Karina Zitta; Martin Albrecht; Norbert Weiler; Stefan Uhlig
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.